|
|
|
|
| LEADER |
00000cam a2200000 7i4500 |
| 001 |
0000092121 |
| 008 |
170808s2016 enk eng |
| 020 |
|
|
|a 1782620303
|
| 020 |
|
|
|a 1782622241
|
| 020 |
|
|
|a 9781782620303
|
| 020 |
|
|
|a 9781782622246
|
| 040 |
|
|
|a UniSZA
|e rda
|
| 050 |
0 |
0 |
|a RS403
|b .P75 2016
|
| 060 |
1 |
0 |
|a QV 744
|b .P945 2016
|
| 090 |
0 |
0 |
|a RS403
|b .P75 2016
|
| 245 |
1 |
0 |
|a Privileged scaffolds in medicinal chemistry
|b design, synthesis, evaluation
|c edited by Stefan Brase
|
| 264 |
|
1 |
|a Cambridge
|b Royal Society of Chemistry
|c c2016
|
| 300 |
|
|
|a xviii, 468 pages
|b illustrations
|c 24 cm.
|
| 336 |
|
|
|a text
|2 rdacontent
|
| 337 |
|
|
|a unmediated
|2 rdamedia
|
| 338 |
|
|
|a volume
|2 rdacarrier
|
| 490 |
1 |
|
|a RSC drug discovery
|v 50
|
| 650 |
|
0 |
|a Drug development
|
| 650 |
|
0 |
|a Molecular pharmacology
|
| 650 |
|
0 |
|a Pharmaceutical chemistry
|
| 650 |
|
2 |
|a Chemistry, Pharmaceutical
|
| 650 |
2 |
2 |
|a Drug Discovery
|
| 650 |
2 |
2 |
|a Heterocyclic Compound
|x chemistry
|
| 700 |
1 |
|
|a Brase, Stefan
|e editor
|
| 999 |
|
|
|a 1000169171
|b Book
|c OPEN SHELF (30 DAYS)
|e Tembila Campus
|